BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1497480)

  • 1. Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals.
    Brady AM; Lock EA
    Arch Toxicol; 1992; 66(3):175-81. PubMed ID: 1497480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of griseofulvin and dihydropyridines on ferrochelatase activity and porphyrin accumulation in primary cultures of mouse and rat hepatocytes.
    Brady AM; Hasmall RL; Elcombe BM
    Toxicol In Vitro; 1993 Sep; 7(5):587-93. PubMed ID: 20732255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of porphyrin-inducing drugs on ferrochelatase activity in isolated mouse hepatocytes.
    Cole SP; Massey TE; Marks GS; Racz WJ
    Can J Physiol Pharmacol; 1981 Nov; 59(11):1155-8. PubMed ID: 7317839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain and sex differences in the response of mice to drugs that induce protoporphyria: role of porphyrin biosynthesis and removal.
    Holley A; King LJ; Gibbs AH; De Matteis F
    J Biochem Toxicol; 1990; 5(3):175-82. PubMed ID: 2283668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of porphyrin accumulation in response to xenobiotics. Parallels between results in chick embryo and rodents.
    Marks GS; Powles J; Lyon M; McCluskey S; Sutherland E; Zelt D
    Ann N Y Acad Sci; 1987; 514():113-27. PubMed ID: 3126696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of 3-ethoxycarbonyl-1,4-dihydro-2,4-dimethylpyridine and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity and heme biosynthesis in chick embryo liver cells in culture.
    Marks GS; Allen DT; Sutherland EP; McCluskey SA; Whitney RA
    Can J Physiol Pharmacol; 1986 Apr; 64(4):483-6. PubMed ID: 3730932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of an N-alkylprotoporphyrin IX from chick embryo livers following the administration of 3,5-diethoxycarbonyl-1,4-dihydro-4-ethyl-2,6-dimethylpyridine.
    McCluskey SA; Sutherland EP; Racz WJ; Marks GS
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1500-2. PubMed ID: 3664364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrochelatase and N-alkylated porphyrins.
    Cole SP; Marks GS
    Mol Cell Biochem; 1984 Sep; 64(2):127-37. PubMed ID: 6390167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of experimental porphyria and ferrochelatase inhibition produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
    Tephly TR; Gibbs AH; Ingall G; De Matteis F
    Int J Biochem; 1980; 12(5-6):993-8. PubMed ID: 7450161
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of the effects of certain drugs on experimental porphyria in rats.
    Deshpande SG; Kandhari KC; Narang BS; Bikhchandani R; Bhutani LK
    Dermatologica; 1977; 154(5):284-90. PubMed ID: 863070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of porphyrin accumulation in response to chemicals in chick embryo liver cells.
    Marks GS; Follows SB; Zelt DT; Cole SP
    Can J Physiol Pharmacol; 1983 Jun; 61(6):546-53. PubMed ID: 6883207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
    Marks GS; Allen DT; Johnston CT; Sutherland EP; Nakatsu K; Whitney RA
    Mol Pharmacol; 1985 Apr; 27(4):459-65. PubMed ID: 3982391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of beta-adrenergic blocking agents on experimental porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in vivo and in vitro.
    Schoenfeld N; Epstein O; Atsmon A
    Biochim Biophys Acta; 1976 Aug; 444(1):286-93. PubMed ID: 8132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of protohaem ferro-lyase in experimental porphyria. Isolation and partial characterization of a modified porphyrin inhibitor.
    De Matteis F; Gibbs AH; Tephly TR
    Biochem J; 1980 Apr; 188(1):145-52. PubMed ID: 7406876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of decreased ferrochelatase activity on iron and porphyrin content in mitochondria of mice with porphyria induced by griseofulvin.
    TangerĂ¥s A
    Biochim Biophys Acta; 1986 Jun; 882(1):77-84. PubMed ID: 3707999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice.
    De Matteis F; Abbritti G; Gibbs AH
    Biochem J; 1973 Jul; 134(3):717-27. PubMed ID: 4749272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver.
    Cole SP; Zelt DT; Marks GS
    Mol Pharmacol; 1981 May; 19(3):477-80. PubMed ID: 7266472
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Griseofulvin on 5-aminolevulinate synthase and on ferrochelatase in mouse liver neoplastic nodules.
    Denk H; Kalt R; Abdelfattach-Gad M; Meyer UA
    Cancer Res; 1981 Apr; 41(4):1535-8. PubMed ID: 7214331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ferrochelatase by N-methylprotoporphyrin IX is not accompanied by delta-aminolevulinic acid synthetase induction in chick embryo liver cell culture.
    Cole SP; Marks GS; Oritz de Montellano PR; Kunze KL
    Can J Physiol Pharmacol; 1982 Feb; 60(2):212-5. PubMed ID: 6896292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
    McCluskey SA; Marks GS; Whitney RA; Ortiz de Montellano PR
    Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.